Bio-Gene Technology proposes 6.5 million incentive options for directors and management
BGT: $0.013 -23.53% · MC: $7M
Bio-Gene Technology proposes issuing 6.5 million options expiring in 2029 as incentives for directors and management. The proposed issue includes 4.5 million options for directors, subject to shareholder approval at the AGM, and 2 million for management, which do not require approval.

Comments